Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol timing and minimum dose for suppression of sufentanil-induced cough
ChiCTR1900024394Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jul 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of butorphanol and sufentanil in cough (8 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Cough response. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
butorphanolsufentanil
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR1900024394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024394.